Rethinking the Regulatory Infrastructure for Human Gene Transfer Clinical Trials.

Jenkins, Christopher L; Bagarazzi, Mark L; Kiem, Hans-Peter; Levine, Arnold J; Ando, Dale; June, Carl H; Reid, Tony; Emery, David W

Jenkins, Christopher L; Bagarazzi, Mark L; Kiem, Hans-Peter; Levine, Arnold J; Ando, Dale; June, Carl H; Reid, Tony; Emery, David W.

Afiliação

Jenkins CL; WCG Biosafety, WIRB-Copernicus Group, Princeton, New Jersey, USA.
Bagarazzi ML; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA.
Kiem HP; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Levine AJ; Institute for Advanced Study, The Simons Center for Systems Biology, Princeton, New Jersey, USA.
Ando D; Therapeutic Development, Sangamo BioSciences, Inc., Richmond, California, USA.
June CH; Department of Pathology and Laboratory Medicine and Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Reid T; Department of Medicine, University of California San Diego Health, La Jolla, California, USA.
Emery DW; WCG Biosafety, WIRB-Copernicus Group, Puyallup, Washington, USA.

Mol Ther ; 24(7): 1173-7, 2016 08.

Article em En | MEDLINE | ID: mdl-27506378

Assuntos

Técnicas de Transferência de Genes; Terapia Genética/tendências; Ensaios Clínicos como Assunto; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Técnicas de Transferência de Genes Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google